Paclitaxel Injection 30mg is a chemotherapy medication used to treat various cancers, including advanced ovarian, breast, and non-small cell lung cancer (NSCLC), as well as AIDS-related Kaposi's sarcoma. It acts by inhibiting cancer cell division and growth, often in combination with other agents, and is administered via intravenous infusion by a healthcare professional
Breast Cancer: Treats node-positive breast cancer and metastatic breast cancer after failure of previous chemotherapy.
Ovarian Cancer: Used as first-line or subsequent therapy for advanced ovarian carcinoma, often in combination with cisplatin.
Non-Small Cell Lung Cancer (NSCLC): Used for the first-line treatment of non-small cell lung cancer in combination with cisplatin, when surgery or radiation is not possible.
AIDS-Related Kaposi's Sarcoma: Used as second-line treatment for advanced AIDS-related Kaposi's sarcoma
Paclitaxel 260 mg Injection IP is a potent chemotherapy medicine used to treat advanced or metastatic cancers, including breast, ovarian, and non-small cell lung cancer, as well as Kaposi's sarcoma. It works by stopping cancer cell division. It is administered by healthcare professionals via IV infusion, often with premedication to reduce allergic reactions.
Breast Cancer: Treats advanced or metastatic breast cancer, often after failure of previous chemotherapy.
Ovarian Cancer: Used as a first-line or subsequent treatment for carcinoma of the ovary.
Non-Small Cell Lung Cancer (NSCLC): Indicated in combination with other agents for advanced NSCLC.
Kaposi's Sarcoma: Used for treating AIDS-related Kaposi's sarcoma, especially when other treatments have failed.
Request Callback
Additional Information:
Delivery Time: 3 TO 4 DAYS
Packaging Details: Paclitaxel 260 Mg Injections
260 MG/43.4 ML
Paclitaxel 100 mg injection IP is a potent chemotherapy medication used primarily to treat advanced breast cancer, ovarian cancer, non-small cell lung cancer (NSCLC), and AIDS-related Kaposi's sarcoma. It works by interfering with cancer cell division, causing them to die. It is administered intravenously by healthcare professionals.
Breast Cancer: Treatment of metastatic breast cancer or following relapse after initial chemotherapy.
Ovarian Cancer: Used as first-line or subsequent therapy for advanced carcinoma of the ovary.
Non-Small Cell Lung Cancer (NSCLC): As part of combination chemotherapy for patients not candidates for curative surgery/radiation.
Kaposi's Sarcoma: Treatment of AIDS-related Kaposi's sarcoma .
Request Callback
Additional Information:
Delivery Time: 3 TO 4 DAYS
Packaging Details: Paclitaxel 100 Mg injection IP
100 MG/16.7ML
